Subscription Program

I understand that I will be charged every 3 months for my cycle subscription.

Ligandrol capsules

LGD-4033
$ 169 
4 payments of
$42.25
with
-
+

90 capsules

per bottle

Free shipping

worldwide

Free shipping

includes

APO/FPO/DPO’s

SARM STATS

Observed performance metrics in laboratory models

No items found.
SARM STATS

Observed performance metrics in laboratory models

oxygenation
2
Protein Synthesis
3
Muscle Fiber Contractile Response
9
Post-Stimulus Repair Activity
5
Thermo genesis
3
Anabolic Volume Index
4
Hydrostatic Load Response
8
Customer Reviews

Ligandrol Research

Research summary on LGD-4033 (also known as Ligandrol or VK-5211).

Ligandrol Overview

Ostarine, also known as Enobosarm or MK-2866, is a non-steroidal selective androgen receptor modulator.

LGD-4033 (Ligandrol) is a Selective Androgen Receptor Modulator (SARM) — known for its potent anabolic activity in muscle and bone tissue.

In research settings, it has been shown to:


✔ Increase lean body mass even at low doses.


✔ Enhance muscle strength and endurance capacity.

✔ Aid recovery from musculoskeletal injury.

💥 MUSCLE HYPERTROPHY:

Clinical studies have shown LGD-4033 to significantly increase lean muscle mass in healthy adults within just weeks of administration.

🪨 STRENGTH GAINS:

Participants in research trials have demonstrated measurable improvements in lifting strength and muscular endurance.

🔄 RECOVERY SUPPORT:

By promoting anabolic signaling, LGD-4033 can aid in tissue repair following injury or intense training.

Research Articles

Top Research Articles on Ligandrol (LGD-4033)

1.Angelis, Yiannis S, Sakellariou, Panagiotis, Petrou, Michael, & Pitsinos, Emmanuel N (2024). Targeted Metabolic Investigation of Ligandrol and Analytical Methods Validation for Its Main Long-term Metabolite.. ChemPlusChem.

https://doi.org/10.1002/cplu.202300634

2. Barbara, Mary, Dhingra, Sadhna, & Mindikoglu, Ayse L (2020). Ligandrol (LGD-4033)-Induced Liver Injury.. ACG case reports journal.

https://doi.org/10.14309/crj.0000000000000370

3. Basaria, Shehzad, Collins, Lauren, Dillon, E Lichar, Orwoll, Katie, Storer, Thomas W, Miciek, Renee, ... Bhasin, Shalender (2013). The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.. The journals of gerontology. Series A, Biological sciences and medical sciences.

https://doi.org/10.1093/gerona/gls078

4. Breuer, Johanna, Thomas, Andreas, Delahaut, Philippe, Schänzer, Wilhelm, Geyer, Hans, & Thevis, Mario (2023). Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry.. Analytical and bioanalytical chemistry.

https://doi.org/10.1007/s00216-022-04456-y

5. Cox, Holly D, & Eichner, Daniel (2017). Detection of LGD-4033 and its metabolites in athlete urine samples.. Drug testing and analysis.

https://doi.org/10.1002/dta.1986

SIGN UP FOR OUR NEWSLETTER
SIGN UP TO GET THE LATEST ON SALES, NEW RELEASES AND MORE!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.